A pharmaceutical company and life insurance firm will not receive any more North Carolina tax incentives for their promised ...

Alcami Corporation, a contract development and manufacturing organization (CDMO), has appointed pharmaceutical industry ...

Frontier Scientific Solutions, a logistics company for pharmaceuticals, is building a new facility at Wilmington International Airport. The 500,000-square-foot facility will be the largest of its kind ...

DetraPel, Inc., a clean-tech advanced materials company, will relocate its headquarters and advanced manufacturing operations ...

Ramona, a Durham provider of advanced imaging technology for life sciences, has launched a live-cell imaging system that ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

When Genentech licensed experimental drug vixarelimab from Kiniksa Pharmaceuticals KNSA0.51%increase; green up pointing triangle, its scientists thought they had a future lung medicine in their ...

Saudi Chemical Co. Holding obtained the Saudi Food and Drug Authority’s (SFDA) approval to register Ticagrelor as a fully locally manufactured product at the AJA Pharmaceutical Industries Ltd. (AJA ...

Can the U.S. pharmaceutical supply chain come home — or ... And, since the mid-2010s, the industry has seen a continuing steady drop in the value of its product that is domestically sourced and ...

Bain Capital has placed a $3.3bn bet on a historic shift in Japan’s conservative drugs approval regime by buying a pharmaceutical ... means products approved by overseas regulators often do ...

Relmada continues to evaluate additional product and strategic opportunities. The Company anticipates hosting an investor update on Sepranolone’s next development steps later in 2025.

Consequently, the forecasting effort is typically limited in scope and depth, focusing on broader market potential, rather than detailed product performance. 2. Early development (Phase I and II ...